VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today provided a company and pipeline update. “In the first six months of 2026, we have made ...
On July 2, ahead of U.S. Independence Day, Oksana Koval, President of the American Industry and Innovation Research ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果